GUANGZHOU, Dec. 23 (Xinhua) -- Some 180,000 people with higher risks of coronavirus infection in south China's Guangdong Province have been given COVID-19 vaccine candidates as of Tuesday, the provincial government said on Wednesday.
No serious side effects have been reported among the vaccine receivers, said the information office of the local government of Guangdong at a press briefing.
The vaccine candidates, still undergoing clinical trials, were made by the China National Biotec Group and Beijing-based Sinovac, said the office.
Guangdong has started a COVID-19 vaccination campaign among groups of people with higher risks of infection. They include medical workers, customs officers, primary-level epidemic prevention workers, overseas returnees, and people working in cross-border cold-chain logistics and isolation centers.
Fire brigade in Shanghai holds group wedding
Tourists enjoy ice sculptures in Datan Town, north China
Sunset scenery of Dayan Pagoda in Xi'an
Tourists have fun at scenic spot in Nanlong Town, NW China
Harbin attracts tourists by making best use of ice in winter
In pics: FIS Alpine Ski Women's World Cup Slalom
Black-necked cranes rest at reservoir in Lhunzhub County, Lhasa
China's FAST telescope will be available to foreign scientists in April
"She power" plays indispensable role in poverty alleviation
Top 10 world news events of People's Daily in 2020
Top 10 China news events of People's Daily in 2020
Top 10 media buzzwords of 2020
Year-ender:10 major tourism stories of 2020
No interference in Venezuelan issues
Biz prepares for trade spat
Broadcasting Continent
Australia wins Chinese CEOs as US loses
